Li Cao

发表

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

Y. Li, Yulei N. Wang, Xiaoqing Chen, 2022, BMC Medicine.

Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node

A. Giuliano, Yulei N. Wang, C. Balch, 2022, Breast Cancer.

Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations

Yulei N. Wang, Bo Chen, N. Liao, 2022, Cancer medicine.

Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours

Yulei N. Wang, Xiaoqing Chen, C. Balch, 2021, EBioMedicine.

Association between histone lysine methyltransferase KMT2C mutation and clinicopathological factors in breast cancer.

Yulei N. Wang, Xiaoqing Chen, Bo Chen, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Association of Body Mass Index With Somatic Mutations in Breast Cancer

Bo Chen, N. Liao, Li-ping Guo, 2021, Frontiers in Oncology.

Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy

Yulei N. Wang, Xiaoqing Chen, C. Balch, 2020, Breast Cancer Research and Treatment.

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer

Yulei N. Wang, Bo Chen, N. Liao, 2020, Aging.

The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.

Yulei N. Wang, Bo Chen, N. Liao, 2020, Gene.

Spectrum of MAP3K1 mutations in breast cancer is luminal subtype-predominant and related to prognosis

Yulei N. Wang, Bo Chen, J. Lai, 2022, Oncology letters.

PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing

Yulei N. Wang, C. Balch, Bo Chen, 2021, Breast Cancer.

Heterogeneity of genomic profile in patients with HER2-positive breast cancer.

Yulei N. Wang, C. Balch, Bo Chen, 2020, Endocrine-related cancer.

Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients

Yulei N. Wang, Xiaoqing Chen, Bo Chen, 2021, Cancer management and research.

Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.

Yulei N. Wang, Xiaoqing Chen, F. Meric-Bernstam, 2019, Annals of translational medicine.

Abstract P4-04-08: Genomic profiling of 304 treatment-naïve Chinese breast cancer patients: A comparison of Chinese and TCGA cohorts

Yulei N. Wang, F. Meric-Bernstam, N. Liao, 2019, Poster Session Abstracts.

Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature

Yulei N. Wang, Bo Chen, J. Lai, 2022, Clinical Medicine Insights. Oncology.

The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects

Lei Yao, Long Yu, Li-xin Qiu, 2010, Breast Cancer Research and Treatment.

Next-generation sequencing (NGS) identifies a new breast cancer subtype with HER2 low-amplification status as a candidate for targeted therapy.

Yulei N. Wang, Bo Chen, J. Lai, 2020 .